Humacyte Acellular Tissue Engineered Vessel (Atev™) Receives Fda’s Regenerative Medicine Advanced Therapy (Rmat) Designation for Patients With Advanced Peripheral Artery Disease (Pad)
Humacyte無細胞組織工程血管（Atev™）獲得美國食品藥品監督管理局的再生醫學先進療法（RMAT）認定，用於治療晚期周圍動脈疾病（PAD）患者。